Arvelle Therapeutics
About:
Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solution.
Website: https://www.arvelletx.com/
Top Investors: Andera Partners, F-Prime Capital, EQT Life Sciences, KB Investment, Novaquest Capital Management
Description:
Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solutions to patients suffering from CNS disorders.
Total Funding Amount:
$222M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Basel, Basel-Stadt, Switzerland
Founded Date:
2019-01-01
Contact Email:
info(AT)arvelletx.com
Founders:
Gregory Weinhoff, Ilise Lombardo, Mark Altmeyer
Number of Employees:
1-10
Last Funding Date:
2020-05-27
IPO Status:
Private
Industries:
© 2025 bioDAO.ai